benzoylarginine-2-naphthylamide has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Bretz, WA; Corby, PM; Harris, T; Kritchevsky, SB; Kurella, M; Newman, AB; Ren, D; Satterfield, S; Visser, M; Weissfeld, L; Weyant, RJ | 1 |
2 other study(ies) available for benzoylarginine-2-naphthylamide and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population.
Topics: Aged; Benzoylarginine-2-Naphthylamide; Biomarkers; C-Reactive Protein; Cohort Studies; Cross-Sectional Studies; Female; Humans; Infections; Inflammation; Interleukin-6; Male; Periodontal Diseases; Plasminogen Activator Inhibitor 1; Prospective Studies; Tumor Necrosis Factor-alpha | 2005 |